Wael M. Rabeh

PO Box 129188, Saadiyat Island
Abu Dhabi, AZ, United Arab Emirates

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach.

Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach.

Journal: Drug design, development and therapy

Published: January 01, 2026

Residues of the ribose binding site are required for human ribokinase activity.

Residues of the ribose binding site are required for human ribokinase activity.

Journal: Journal of structural biology: X

Published: September 08, 2025

Mapping the structural dynamics of red- and blue-emitting beetle luciferases revealed by HDX-MS.

Mapping the structural dynamics of red- and blue-emitting beetle luciferases revealed by HDX-MS.

Journal: Life science alliance

Published: May 10, 2025

Hexokinase 2 is an RNA-binding protein that regulates mRNA translation independently of glycolysis and induces melanoma cell proliferation.

Hexokinase 2 is an RNA-binding protein that regulates mRNA translation independently of glycolysis and induces melanoma cell proliferation.

Journal: PLoS biology

Published: January 08, 2025

Identification of novel allosteric sites of SARS-CoV-2 papain-like protease (PLpro) for the development of COVID-19 antivirals.

Identification of novel allosteric sites of SARS-CoV-2 papain-like protease (PLpro) for the development of COVID-19 antivirals.

Journal: The Journal of biological chemistry

Published: June 06, 2024

Boosting immunity: synergistic antiviral effects of luteolin, vitamin C, magnesium and zinc against SARS-CoV-2 3CLpro.

Boosting immunity: synergistic antiviral effects of luteolin, vitamin C, magnesium and zinc against SARS-CoV-2 3CLpro.

Journal: Bioscience reports

Published: May 17, 2024

Residues in the fructose-binding pocket are required for ketohexokinase-A activity.

Residues in the fructose-binding pocket are required for ketohexokinase-A activity.

Journal: The Journal of biological chemistry

Published: March 06, 2024

3-chymotrypsin-like protease in SARS-CoV-2.

3-chymotrypsin-like protease in SARS-CoV-2.

Journal: Bioscience reports

Published: January 31, 2024

Discovery of pyrimidoindol and benzylpyrrolyl inhibitors targeting SARS-CoV-2 main protease (Mpro) through pharmacophore modelling, covalent docking, and biological evaluation.

Discovery of pyrimidoindol and benzylpyrrolyl inhibitors targeting SARS-CoV-2 main protease (Mpro) through pharmacophore modelling, covalent docking, and biological evaluation.

Journal: Journal of molecular graphics & modelling

Published: September 15, 2023

The Discovery of Novel Small Oxindole-Based Inhibitors Targeting the SARS-CoV-2 Main Protease (Mpro ).

The Discovery of Novel Small Oxindole-Based Inhibitors Targeting the SARS-CoV-2 Main Protease (Mpro ).

Journal: Chemistry & biodiversity

Published: August 07, 2023

SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses.

SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: January 30, 2023

Key Allosteric and Active Site Residues of SARS-CoV-2 3CLpro Are Promising Drug Targets.

Key Allosteric and Active Site Residues of SARS-CoV-2 3CLpro Are Promising Drug Targets.

Journal: The Biochemical journal

Published: January 30, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026